Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) in outpatient clinics - results of the outpatient MDS registry

被引：0
|
作者：
Schmitz, S. [1 ]
Boettger, I [1 ]
Welslau, M. [1 ]
Lerchenmueller, C. [1 ]
Sauer, A. [1 ]
Germing, U. [1 ]
机构：
[1] Univ Klin Dusseldorf, Dusseldorf, Germany
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：289 / 289
页数：1
相关论文
共 50 条
  • [21] Treatment of Lower Risk Myelodysplastic Syndromes MDS
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S69 - S70
  • [22] Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS)
    Valent, P
    Wimazal, F
    Schwarzinger, I
    Sperr, WR
    Geissler, K
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (13-14) : 515 - 536
  • [23] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
    Steensma, D.
    Abedi, M.
    Bejar, R.
    Cogle, C.
    Foucar, K.
    Garcia-Manero, G.
    George, T.
    Grinblatt, D.
    Komrokji, R.
    Maciejewski, J.
    Pollyea, D.
    Roboz, G.
    Savona, M.
    Scott, B.
    Sekeres, M.
    Thompson, M.
    Sugrue, M.
    Swern, A.
    Nifenecker, M.
    Erba, H.
    LEUKEMIA RESEARCH, 2015, 39 : S124 - S124
  • [24] Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
    Kasprzak, Annika
    Nachtkamp, Kathrin
    Gattermann, Norbert
    Germing, Ulrich
    CANCERS, 2022, 14 (08)
  • [25] INTENSIVE CHEMOTHERAPY FOR PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    BERNSTEIN, SH
    BRUNETTO, VL
    DAVEY, FR
    MAYER, RJ
    WURSTERHILL, D
    SCHIFFER, CA
    BLOOMFIELD, CD
    BLOOD, 1993, 82 (10) : A196 - A196
  • [26] Factors Associated with Early Therapy Initiation in Patients (pts) with Myelodysplastic Syndromes (MDS) in the Connect® MDS/AML Disease Registry
    Cogle, Christopher R.
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Komrokji, Rami S.
    Savona, Michael R.
    Scott, Bart L.
    Sekeres, Mikkael A.
    Louis, Chrystal U.
    Flick, E. Dawn
    Nifenecker, Melissa
    Kiselev, Pavel
    Swern, Arlene S.
    Steensma, David P.
    BLOOD, 2018, 132
  • [27] Mutations in splicing factor genes and their diagnostic impact on patients with myelodysplastic syndromes (MDS)
    Aghova, Tatiana
    Lhotska, Halka
    Svobodova, Karla
    Hodanova, Lucie
    Lizcova, Libuse
    Pavlistova, Lenka
    Luksikova, Karolina
    Sotakova, Slavka
    Minarik, Lubomir
    Stopka, Tomas
    Jonasova, Anna
    Zemanova, Zuzana
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 605 - 606
  • [28] Influence of different treatment strategies on the prognosis of patients with myelodysplastic syndromes (MDS)
    Nachtkamp, K.
    Kuendgen, A.
    Strupp, C.
    Gattermann, N.
    Giagounidis, A.
    Haas, R.
    Germing, U.
    LEUKEMIA RESEARCH, 2007, 31 : S30 - S30
  • [29] Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
    Valent, Peter
    Orazi, Attilio
    Steensma, David P.
    Ebert, Benjamin L.
    Haase, Detlef
    Malcovati, Luca
    van de Loosdrecht, Arjan A.
    Haferlach, Torsten
    Westers, Theresia M.
    Wells, Denise A.
    Giagounidis, Aristoteles
    Loken, Michael
    Orfao, Alberto
    Luebbert, Michael
    Ganser, Arnold
    Hofmann, Wolf-Karsten
    Ogata, Kiyoyuki
    Schanz, Julie
    Bene, Marie C.
    Hoermann, Gregor
    Sperr, Wolfgang R.
    Sotlar, Karl
    Bettelheim, Peter
    Stauder, Reinhard
    Pfeilstoecker, Michael
    Horny, Hans-Peter
    Germing, Ulrich
    Greenberg, Peter
    Bennett, John M.
    ONCOTARGET, 2017, 8 (43) : 73483 - 73500
  • [30] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Germing, Ulrich
    Haferlach, Torsten
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
12345